| Primary |
| Product Used For Unknown Indication |
85.7% |
| Intentional Self-injury |
3.4% |
| Pain |
2.5% |
| Self Injurious Behaviour |
2.5% |
| Substance Use |
1.7% |
| Back Pain |
0.8% |
| Depression |
0.8% |
| Migraine |
0.8% |
| Pain In Extremity |
0.8% |
| Sleep Disorder Therapy |
0.8% |
|
| Vomiting |
20.0% |
| Overdose |
15.0% |
| Toxicity To Various Agents |
15.0% |
| Suicide Attempt |
10.0% |
| Prothrombin Time Prolonged |
7.5% |
| Self Injurious Behaviour |
7.5% |
| Drug-induced Liver Injury |
2.5% |
| Intentional Self-injury |
2.5% |
| International Normalised Ratio Increased |
2.5% |
| Nausea |
2.5% |
| Shock |
2.5% |
| Tachycardia |
2.5% |
| Toxic Epidermal Necrolysis |
2.5% |
| Transaminases Increased |
2.5% |
| Unevaluable Event |
2.5% |
| Ventricular Arrhythmia |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
81.6% |
| Intentional Self-injury |
3.2% |
| Abdominal Pain |
2.4% |
| Self Injurious Behaviour |
2.4% |
| Substance Use |
1.6% |
| Alcohol Abuse |
0.8% |
| Back Pain |
0.8% |
| Depression |
0.8% |
| Drug Dependence |
0.8% |
| Headache |
0.8% |
| Hypertension |
0.8% |
| Migraine |
0.8% |
| Pain |
0.8% |
| Pain In Extremity |
0.8% |
| Renal Cancer |
0.8% |
| Vitamin Supplementation |
0.8% |
|
| Vomiting |
18.2% |
| Overdose |
13.6% |
| Toxicity To Various Agents |
13.6% |
| Prothrombin Time Prolonged |
6.8% |
| Self Injurious Behaviour |
6.8% |
| Suicide Attempt |
6.8% |
| Drug Hypersensitivity |
4.5% |
| Drug-induced Liver Injury |
2.3% |
| Intentional Overdose |
2.3% |
| Intentional Self-injury |
2.3% |
| Nausea |
2.3% |
| Pain |
2.3% |
| Premature Baby |
2.3% |
| Shock |
2.3% |
| Skin Lesion |
2.3% |
| Somnolence |
2.3% |
| Stevens-johnson Syndrome |
2.3% |
| Substance Abuse |
2.3% |
| Tachycardia |
2.3% |
| Toxic Epidermal Necrolysis |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.2% |
| Premedication |
12.9% |
| Analgesic Therapy |
4.3% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Pain |
3.1% |
| Atrial Fibrillation |
2.8% |
| Bipolar Disorder |
2.8% |
| Gout |
2.8% |
| Sedation |
2.8% |
| Rheumatoid Arthritis |
2.5% |
| Arthritis |
2.1% |
| Contraception |
2.1% |
| Hormone Replacement Therapy |
2.1% |
| Vitamin Supplementation |
2.1% |
| Anxiety |
1.8% |
| Crohn's Disease |
1.8% |
| Hepatitis C |
1.8% |
| Lymphoma |
1.8% |
| Ankylosing Spondylitis |
1.5% |
| Colitis Ulcerative |
1.5% |
|
| Pulmonary Embolism |
8.5% |
| Pyrexia |
8.5% |
| Vomiting |
8.5% |
| Renal Failure Acute |
6.8% |
| Pain |
5.1% |
| Rash |
5.1% |
| Respiratory Failure |
5.1% |
| Sepsis |
5.1% |
| Therapeutic Response Decreased |
5.1% |
| Thrombosis |
5.1% |
| Upper Gastrointestinal Haemorrhage |
5.1% |
| Weight Decreased |
5.1% |
| Granulocytopenia |
3.4% |
| International Normalised Ratio Increased |
3.4% |
| Product Contamination |
3.4% |
| Rhinorrhoea |
3.4% |
| Toxicity To Various Agents |
3.4% |
| Traumatic Liver Injury |
3.4% |
| Treatment Noncompliance |
3.4% |
| Unevaluable Event |
3.4% |
|
